Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Major Shareholder Sells $339,217.64 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHGet Free Report) major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $5.51, for a total value of $339,217.64. Following the transaction, the insider now owns 1,453,948 shares in the company, valued at approximately $8,011,253.48. This trade represents a 4.06 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Stock Performance

Shares of AVAH stock traded down $0.05 during mid-day trading on Thursday, hitting $5.46. The company’s stock had a trading volume of 204,391 shares, compared to its average volume of 236,961. The company’s fifty day simple moving average is $4.63 and its 200-day simple moving average is $4.96. Aveanna Healthcare Holdings Inc. has a 52 week low of $2.11 and a 52 week high of $6.19. The company has a market cap of $1.06 billion, a PE ratio of -16.06 and a beta of 2.25.

Hedge Funds Weigh In On Aveanna Healthcare

A number of hedge funds have recently added to or reduced their stakes in AVAH. KLP Kapitalforvaltning AS acquired a new position in Aveanna Healthcare during the 4th quarter valued at about $35,000. BNP Paribas Financial Markets purchased a new position in shares of Aveanna Healthcare in the 4th quarter worth approximately $35,000. Tower Research Capital LLC TRC boosted its stake in shares of Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock worth $36,000 after buying an additional 6,854 shares during the last quarter. Catalyst Funds Management Pty Ltd boosted its stake in shares of Aveanna Healthcare by 321.4% in the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock worth $54,000 after buying an additional 9,000 shares during the last quarter. Finally, Sagespring Wealth Partners LLC purchased a new position in shares of Aveanna Healthcare in the 4th quarter worth approximately $57,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AVAH. UBS Group increased their price target on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a “sell” rating in a research report on Friday, March 14th. Truist Financial reduced their price target on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating on the stock in a research report on Monday, January 6th.

Get Our Latest Stock Analysis on AVAH

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Further Reading

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.